Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein

Xiaojing Cong1, Salvatore Bongarzone, Gabriele Giachin

  • 1Department of Physics, Scuola Internazionale Superiore di Studi Avanzati-SISSA, Via Bonomea 265, 34136 Trieste, Italy.

Insights

Prion protein (PrP) mutations cause disease. Molecular dynamics simulations reveal that specific helix interactions are key for prion propagation, while loop conformations influence dominant-negative effects in prion diseases.

Area of Science:

  • Structural biology
  • Neuroscience
  • Biochemistry

Background:

  • Prion diseases arise from mutations in the prion protein (PrP).
  • PrP mutations influence susceptibility to prion strains and can exhibit dominant-negative effects, inhibiting wild-type PrP conversion.
  • Understanding PrP structure is crucial for elucidating prion disease mechanisms.

Purpose of the Study:

  • To investigate the structural basis of prion propagation and dominant-negative effects.
  • To analyze the molecular dynamics of human (Hu) PrP, mouse (Mo) PrP, and chimeric PrP structures.

Main Methods:

  • All-atom molecular dynamics (MD) simulations were employed.
  • Simulations were conducted in explicit solvent for approximately 2 microseconds.
  • Structural analysis focused on HuPrP, MoPrP, and various Hu/MoPrP and Mo/sheepPrP chimeras.

Main Results:

  • Interactions between the α1 helix and the N-terminal region of the α3 helix were identified as critical for prion propagation.
  • The conformation of the β2-α2 loop was found to play a significant role in the dominant-negative effect observed in some PrP mutations.
  • Distinct structural dynamics were observed across different PrP variants.

Conclusions:

  • Specific α1-α3 helix interactions are essential for the propagation of prions.
  • The β2-α2 loop conformation is a key determinant of the dominant-negative inhibition of prion replication.
  • These findings provide structural insights into the molecular mechanisms underlying prion diseases.